A truncated von willebrand factor (vWF) for increasing the in vitro stability of coagulation factor VIII
AU2026210754A1Pending Publication Date: 2026-08-20CSL BEHRING LENGNAU AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026210754
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-07-29
- Publication Date
- 2026-08-20
Abstract
Abstract The present invention relates to the use of a polypeptide comprising a truncated von Willebrand Factor (VWF) for increasing the in vitro stability of coagulation factor VIII (FVIII) in a composition comprising said FVIII and said polypeptide, wherein the molar ratio of the 5 polypeptide to the FVIII in the composition is greater than 20. 5 20 26 21 07 54 29 J ul 2 02 6 2 0 2 6 2 1 0 7 5 4 2 9 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art